Astera Labs, Inc. $ALAB Shares Sold by Caitong International Asset Management Co. Ltd

Caitong International Asset Management Co. Ltd lessened its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 89.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 754 shares of the company’s stock after selling 6,531 shares during the period. Caitong International Asset Management Co. Ltd’s holdings in Astera Labs were worth $68,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Fred Alger Management LLC raised its holdings in Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after acquiring an additional 179,638 shares during the last quarter. Hoey Investments Inc. raised its holdings in Astera Labs by 22.4% in the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock valued at $553,000 after acquiring an additional 1,121 shares during the last quarter. Wealth Effects LLC acquired a new stake in Astera Labs in the 2nd quarter valued at about $242,000. Maryland State Retirement & Pension System raised its holdings in Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after acquiring an additional 1,906 shares during the last quarter. Finally, Realta Investment Advisors acquired a new stake in Astera Labs in the 2nd quarter valued at about $214,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 91,441 shares of Astera Labs stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer directly owned 2,170,877 shares in the company, valued at $398,377,638.27. This trade represents a 4.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of Astera Labs stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the sale, the director owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is currently owned by company insiders.

Astera Labs Trading Up 0.8%

Astera Labs stock opened at $164.97 on Friday. The stock has a market cap of $27.42 billion, a P/E ratio of 294.59, a price-to-earnings-growth ratio of 4.08 and a beta of 1.43. The company has a fifty day simple moving average of $196.79 and a 200-day simple moving average of $131.41. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company’s revenue for the quarter was up 149.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ALAB has been the subject of a number of recent research reports. Citigroup increased their price objective on shares of Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, September 17th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, September 2nd. TD Cowen started coverage on shares of Astera Labs in a research report on Wednesday, October 1st. They set a “hold” rating and a $200.00 price objective for the company. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective for the company. in a research report on Tuesday, July 22nd. Finally, Needham & Company LLC increased their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $162.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.